Literature DB >> 20201810

Disulfiram: an old therapeutic with new applications.

Kelly S Barth1, Robert J Malcolm.   

Abstract

Disulfiram treatment, despite its limitations, remains a viable option as a treatment for alcohol dependence and has shown recent promise in treating (1) those with co-morbid alcohol dependence and post-traumatic stress disorder, (2) those with co-morbid cocaine- and alcohol-dependence, and (3) those with cocaine-dependence alone. Although disulfiram's mechanism of action in alcohol dependence was long thought to be its effects as a psychological deterrent, more recent studies have uncovered potential anti-craving effects as well as direct effects of disulfiram on cocaine abuse, highlighting a few of the many potential and unique benefits disulfiram may have through its inhibition of dopamine beta-hydroxylase. This article will review the major clinical trials of disulfiram spanning nearly 60 years. We will discuss the pharmacodynamics and pharmacokinetics of disulfiram, indications and limitations of its use, suggestions for appropriate patient populations, and monitoring for compliance and adverse effects. We will also review recent literature on newer potential applications for disulfiram use via its unique action on dopamine beta-hydroxylase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201810     DOI: 10.2174/187152710790966678

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  26 in total

1.  The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.

Authors:  Jan S Moreb; Deniz Ucar; Shuhong Han; John K Amory; Alex S Goldstein; Blanca Ostmark; Lung-Ji Chang
Journal:  Chem Biol Interact       Date:  2011-11-03       Impact factor: 5.192

2.  Functional neural changes following behavioral therapies and disulfiram for cocaine dependence.

Authors:  Elise E DeVito; Guangheng Dong; Hedy Kober; Jiansong Xu; Kathleen M Carroll; Marc N Potenza
Journal:  Psychol Addict Behav       Date:  2017-07-17

Review 3.  Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions.

Authors:  Kari A Mergenhagen; Bethany A Wattengel; Megan K Skelly; Collin M Clark; Thomas A Russo
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

4.  Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolism.

Authors:  Elinore F McCance-Katz; Valerie A Gruber; George Beatty; Paula Lum; Qing Ma; Robin DiFrancesco; Jill Hochreiter; Paul K Wallace; Morris D Faiman; Gene D Morse
Journal:  Am J Addict       Date:  2013-10-11

Review 5.  Rodent models of genetic contributions to motivation to abuse alcohol.

Authors:  John C Crabbe
Journal:  Nebr Symp Motiv       Date:  2014

6.  Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial.

Authors:  Sulggi A Lee; Julian H Elliott; James McMahon; Wendy Hartogenesis; Namandje N Bumpus; Jeffrey D Lifson; Robert J Gorelick; Peter Bacchetti; Steven G Deeks; Sharon R Lewin; Radojka M Savic
Journal:  Clin Pharmacol Ther       Date:  2018-10-09       Impact factor: 6.875

7.  RECK impedes DNA repair by inhibiting the erbB/JAB1/Rad51 signaling axis and enhances chemosensitivity of breast cancer cells.

Authors:  Kun-Jing Hong; Ming-Chuan Hsu; Wen-Chun Hung
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

8.  Assessment of the effects of contingent histamine injections on the reinforcing effectiveness of cocaine using behavioral economic and progressive-ratio designs.

Authors:  Kevin B Freeman; Brian C McMaster; Peter G Roma; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2014-01-08       Impact factor: 4.530

9.  Identification and characterization of small molecule inhibitors of a plant homeodomain finger.

Authors:  Elise K Wagner; Nidhi Nath; Rod Flemming; John B Feltenberger; John M Denu
Journal:  Biochemistry       Date:  2012-10-02       Impact factor: 3.162

Review 10.  Serotonergic gene variation in substance use pharmacotherapy: a systematic review.

Authors:  Isabelle E Bauer; David P Graham; Jair C Soares; David A Nielsen
Journal:  Pharmacogenomics       Date:  2015-08-12       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.